Haisco Pharmaceutical Hits Day Low at CNY 42.38 Amid Price Pressure

Haisco Pharmaceutical Group Co., Ltd. experienced a notable decline in its stock performance today, with a decrease of 4.56%. The stock reached an intraday low of CNY 42.38, reflecting a challenging trading session. Over the past week, Haisco has seen a significant drop of 9.41%, while its performance over the past month stands at a decline of 8.8%. Despite a year-to-date performance of -16.35%, Haisco has shown resilience over a longer timeframe, with a three-year growth of 72.55% and a five-year increase of 113.48%. The company's market capitalization is currently CNY 25,698 million, placing it in the large-cap category within the Pharmaceuticals & Biotechnology industry. Key financial metrics indicate a price-to-earnings ratio of 141.00 and a return on equity of 7.32%. The company also maintains a dividend yield of 0.59%. However, the long-term growth outlook appears subdued, with net sales growing at an annual rate of 2.89% and operating profit declining by 12.72% over the last five years.